Kristensen 2016.

Study characteristics
Study design	Cohort
Study setting	Setting: Rigshospitalet Country: Denmark Dates: cases diagnosed between 2005 and 2010. Study ended 2015
Selection of participants	Participants had available samples and received Stupp regimen
Participant characteristics	Sample size: 151 (deaths: 146) Age: median 59, SD NR; range 22–74 years Sex: 62.9% men KPS: NR
Tumour characteristics	GBM: 100% First diagnosis: NR Biopsy: 3.3%; subtotal resection: NR; total resection: 41.1%; NR IDH1 wild‐type: 96%; IDH2 wild‐type: NR
Treatment regimen	Stupp protocol
MGMT promoter methylation tests implemented	IHC, qMSP‐PSQ
Dates and follow‐up	Timing of MGMT assessment: at diagnosis Start time for follow‐up: NR; follow‐up: median 94; range 53–123 months
Notes